Replies to post #21689 on Cytodyn Inc (CYDY)

[trding]

Management has made such horrible decisions that we are left here running out of money at $.52 instead of $.80 because management made a boneheaded decision to announce a very risky RS that they weren’t even eligible to do in the first place and effectively killing the run up from PE. This is following the boneheaded decision to raise $10mm one trading day before announcing strong PE and effectively damping the only momentum we’ve had in a year before it even started.

I agree with you on both points. Hopefully people are taking advantage of it and loading shares at a greatly reduced discount to what they should have been; I loaded all I could under 50. But things are looking up on sp end, once we get through the shares from the idiot that is putting up 50k blocks on the ask, we should start the up trend. Unless of course we get another boneheaded move from management, which I don't believe will happen at this point--I am guessing they have more of a focus on cause/effect with share price after that. Definitely seemed that way with the PR this week at a critical pivot point IMO.

[misiu143]

Woodenbear - I agree that somethings probably could be done little different , business is not my strong point so I will not comment to much.

We all will like everything to be finish much sooner of course.

I believe that Maraviroc Phase 3, PE was done 2 years on treatment ,
not 1 week like Pro 140 , study with few thousands patients , not 50 like Pro 140, done over few years ( I think 5 years ) and not 25 weeks like with Pro 140.

This is my recollection , maybe somebody will care to confirm that .

This time difference , and number of patients telling me how positive FDA must be about Pro 140.

I am also convince that we will not run out of the money .

HIV is a terrible , terrible disease , and if Pro 140 will be working well , in 2019 it will be approve, I am convince about that.... well, imo.

Some dilution will happen , but we will be going to a very big market,
so imo , not that important.